AP
KDNY

Atwood & Palmer’s Chinook Therapeutics, Inc. Common Stock KDNY Stock Holding History

Atwood & Palmer’s Portfolio KDNY Stock Details KDNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-24
Closed -$2K – 438
2015
Q3 		$2K Buy
+24
New +$2.86K ﹤0.01% 412

Other funds holding KDNY

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
FCMI
Foresite Capital Management II Larkspur, California $29.2M AUM 44.84% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
ORI
Oak Ridge Investments Chicago, Illinois $1.77B AUM 63.16% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
MAM
Marquette Asset Management Minneapolis, Minnesota $779M AUM 23.4% 1-Year Est. Return

Atwood & Palmer's KDNY Position: Q4 2015 in Review

Atwood & Palmer sold out of Chinook Therapeutics, Inc. Common Stock (KDNY) in Q4 2015, closing a stake of 24 shares — an estimated $2K sold.

Atwood & Palmer first reported a position in KDNY in Q3 2015 and held it in 1 quarter. The position peaked at $2K in Q3 2015. 87 funds tracked by Wall St. Rank hold KDNY as of Q4 2015.

  • Atwood & Palmer reported no remaining Chinook Therapeutics, Inc. Common Stock position as of Q4 2015 after selling out during the quarter.
  • Atwood & Palmer sold 24 Chinook Therapeutics, Inc. Common Stock shares in Q4 2015, an estimated $2K.
  • Atwood & Palmer first reported a position in Chinook Therapeutics, Inc. Common Stock in Q3 2015 and held it in 1 quarter.
  • Atwood & Palmer's Chinook Therapeutics, Inc. Common Stock position peaked at $2K in Q3 2015.
  • 87 funds tracked by Wall St. Rank held Chinook Therapeutics, Inc. Common Stock as of Q4 2015.

Based on Atwood & Palmer's 13F filing for Q4 2015, filed 28 Jan 2016.